Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : How high will Microsoft fly? -- Ignore unavailable to you. Want to Upgrade?

To: t2 who wrote (23634)	6/4/1999 4:15:00 PM
From: johnd	Read Replies (1) \| Respond to of 74651

Let us hope for 85+ by end of next week and 90+ by week after which is option exp week. Then 100 by month end; that would be nice

To: t2 who wrote (23634)	6/4/1999 4:26:00 PM
From: Sir Francis Drake	Respond to of 74651

tK2 - 80 is now resistance, but not a big deal seems. Of course if you go by what ML says, we are only 6 1/2 points away from the 12 month target, and two more days like today, and we should reach it - or alternatively, if we go up by 1/2 point a month, we'll hit it in 12 months. This is how absurd these analysts are. Just love 'em. Unfortunately it seems to me that MSFT is going to be a bit range-bound, though hopefully in the 80s not the 70 over the next couple of weeks. As to PFE - don't worry, drug stocks almost never stage moves like PFE did today. Ordinarily I invest in drug stocks (PFE, BMY, JNJ), but I don't trade them. The only reason I decided to trade PFE, is because as I wrote a few days ago, PFE under 105 is too tempting, and I felt it had the potential to rally explosively, which it did, and so was suitable for a trade. Similar situation with QCOM, which I felt was way oversold in the 80's which is why I felt it was a buy. Anyway, I don't see much sense it trading drug stocks under ordinary circumstances. As for MSFT - gotta love it - long term its as sure a winner as anything can be in the stock market (or at least over the next 2-3 years, IMO). Morgan